Cover Image
市場調查報告書

日本的糖尿病市場:患者數、盛行率、口服抗糖尿病藥物、胰島素、診斷

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

出版商 IMARC Services Pvt. Ltd. 商品編碼 345919
出版日期 內容資訊 英文 49 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
日本的糖尿病市場:患者數、盛行率、口服抗糖尿病藥物、胰島素、診斷 Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics
出版日期: 2017年02月15日 內容資訊: 英文 49 Pages
簡介

本報告提供日本的糖尿病市場相關調查分析,現在、未來趨勢 (盛行率、人口統計、診斷、治療) 相關驗證,流行病學,市場趨勢,治療結構,競爭結構,市場預測等系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 糖尿病概要

  • 所謂糖尿病
  • 糖尿病的診斷和治療
  • 糖尿病的併發症

第4章 促進日本的糖尿病市場的主要原因

第5章 日本的糖尿病的流行病學

  • 糖尿病人口和盛行率
  • 人口和盛行率:各糖尿病類型 (一型、2型)
  • 人口和盛行率:各地區
  • 人口和盛行率:性別
  • 人口和盛行率:各年齡層
  • 糖尿病的診斷與藥物治療率

第6章 日本的糖尿病市場

  • 過去的市場趨勢
  • 市場預測
  • 市場明細:各市場區隔
  • 日本的口服抗糖尿病藥物市場
  • 日本的胰島素市場

第7章 日本的糖尿病診斷市場

  • 過去的市場趨勢
  • 市場區隔
  • 主要企業

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SRP00116HA

IMARC's new report "Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics" provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japan diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Japan diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Japanese diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in Japan
  • Historical, current and future prevalence of type-1 and type-2 diabetes in Japan
  • Historical, current and future prevalence of diabetes in the urban and rural regions in Japan
  • Historical, current and future prevalence of diabetes among males and females in Japan
  • Historical, current and future prevalence of diabetes among various age groups in Japan
  • Historical, current and future diagnosis rates for diabetes in Japan
  • Historical, current and future drug treatment rates for diabetes in Japan

Comprehensive situation analysis of the Japanese Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in Japan
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Japanese Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in Japan
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Japanese diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in Japan
  • Market Segmentation
  • Key players
  • Market outlook

Table of Contents

1 Preface

2 Research Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Diabetes Disease Overview

  • 5.1 What is Diabetes?
  • 5.2 Diabetes Diagnosis and Treatment
    • 5.2.1 Diagnosis
    • 5.2.2 Treatment
  • 5.3 Diabetes Complications

6 Japan Diabetes Epidemiology

  • 6.1 Diabetes Population and Prevalence Rates
  • 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 6.3 Population and Prevalence Rates by Region
  • 6.4 Population and Prevalence Rates by Gender
  • 6.5 Population and Prevalence Rates by Age Group

7 Japan Diabetes Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Market Forecast
  • 7.4 SWOT Analysis
    • 7.4.1 Strengths
    • 7.4.2 Weaknesses
    • 7.4.3 Opportunities
    • 7.4.4 Threats
  • 7.5 Value Chain Analysis
  • 7.6 Porter's Five Forces Analysis
    • 7.6.1 Overview
    • 7.6.2 Bargaining Power of Buyers
    • 7.6.3 Bargaining Power of Suppliers
    • 7.6.4 Degree of Competition
    • 7.6.5 Threat of New Entrants
    • 7.6.6 Threat of Substitutes
  • 7.7 Market Breakup by Segment
    • 7.7.1 Japan Oral Antidiabetics Market
      • 7.7.1.1 Historical Market Trends
      • 7.7.1.2 Market Breakup by Class
      • 7.7.1.3 Market Shares of Key Players
      • 7.7.1.4 Market Forecast
    • 7.7.2 Japan Insulin Market
      • 7.7.2.1 Historical Market Trends
      • 7.7.2.2 Market Breakup by Class
      • 7.7.2.3 Market Shares of Key Players
      • 7.7.2.4 Market Forecast
  • 7.8 Competitive Landscape
    • 7.8.1 Competitive Structure
    • 7.8.2 Profiles of Key Players

List of Figures

  • Figure 1: The Impact of Diabetes in the Human Body
  • Figure 2: Diabetes Complications
  • Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2016 & 2035
  • Figure 4: Japan: Overweight & Obese Population* (in Million), 2010, 2016 & 2022
  • Figure 5: Body Mass Index and Relative risk of Type-2 Diabetes
  • Figure 6: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
  • Figure 7: Japan: Diabetes Prevalence By Age Groups, (in %)
  • Figure 8: Japan: Total Number of Diabetes Patients* (in 000), 2009-2016
  • Figure 9: Japan: Total Number of Diabetes Patients* Forecast (in 000), 2017-2022
  • Figure 10: Japan (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2009- 2016
  • Figure 11: Japan (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2017-2022
  • Figure 12: Japan (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2009 -2022
  • Figure 13: Japan (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2017 - 2022
  • Figure 14: Japan (Male & Female): Total Number of Diabetes Patients* (in 000), 2009 - 2016
  • Figure 15: Japan (Male & Female): Total Number of Diabetes Patients* (in 000), 2017 - 2022
  • Figure 16: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2009 - 2016
  • Figure 17: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2017 - 2022
  • Figure 18: Japan: Diabetes Drug Industry Overview
  • Figure 19: Japan: Diabetes Drug Market (in Million US$), 2009 - 2016
  • Figure 20: Japan: Diabetes Drug Market Forecast (in Million US$), 2017 - 2022
  • Figure 21: Japan: Diabetes Drug Market: SWOT Analysis
  • Figure 22: Japan: Diabetes Drug Market: Value Chain Analysis
  • Figure 23: Japan: Diabetes Drug Market: Porters Five Forces Analysis
  • Figure 24: Japan: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2009 - 2016
  • Figure 25: Japan: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2017 - 2022
  • Figure 26: Japan: Oral Antidiabetics Market: (in Million US$), 2009 - 2016
  • Figure 27: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2009 & 2016
  • Figure 28: Japan: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
  • Figure 29: Japan: Oral Antidiabetics Market: (in Million US$), 2017 - 2022
  • Figure 30: Japan: Insulin Market, (in Million US$), 2009 - 2016
  • Figure 31: Japan: Breakup of Insulin Market by Class (in %)
  • Figure 32: Japan: Insulin Market: Sales Share of Key Players (in %)
  • Figure 33: Japan: Insulin Market Forecast (in Million US$), 2017 - 2022

List of Tables

  • Table 1: Diagnosis of Diabetes
  • Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2016 & 2035
  • Table 3: Japan: Overweight &Obesity Statistics, 2010, 2016 & 2022
  • Table 4: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
  • Table 5: Japan: Total Prevalence & Number of Diabetes Patients*, 2009, 2016 & 2022
  • Table 6: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
  • Table 7: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
  • Table 8: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
  • Table 9: Japan: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2009, 2016 & 2022
  • Table 10: Japan: Diabetes Drug Market: Competitive Structure
Back to Top